Novartis Ag (NVSEF) Revenue (QoQ) (2009 - 2023)

Novartis Ag (NVSEF) Revenue (QoQ) (2009 - 2023) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2023 3,429.94%
Mar 31, 2023 27.56%
Dec 31, 2022 7.63%
Sep 30, 2022 -98.15%
Jun 30, 2022 4,873.15%
Mar 31, 2022 -98.99%
Dec 31, 2021 11,124.34%
Sep 30, 2021 -98.26%
Jun 30, 2021 4,510.68%
Mar 31, 2021 16.12%
Dec 31, 2020 1.68%
Sep 30, 2020 -97.90%
Jun 30, 2020 4,647.70%
Jun 30, 2019 4,905.96%
Mar 31, 2019 3.07%
Dec 31, 2018 -10.59%
Sep 30, 2018 -98.06%
Jun 30, 2018 6,106.60%
Mar 31, 2018 4.95%
Dec 31, 2017 5.21%